Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Research article

HIF1α isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation

Nastaran Monsef1*, Maria Soller2, Ioannis Panagopoulos2 and Per Anders Abrahamsson3

Author Affiliations

1 Department of Laboratory Medicine, Division of Pathology, Lund University Hospital, Sweden

2 Department of Clinical Genetics, Lund University Hospital, Sweden

3 Department of Clinical Sciences, Division of Urological Cancer, Malmö University Hospital, Lund University, Sweden

For all author emails, please log on.

BMC Cancer 2010, 10:385  doi:10.1186/1471-2407-10-385

Published: 21 July 2010

Abstract

Background

Neuroendocrine (NE) differentiation in prostate cancer has been correlated with a poor prognosis and hormone refractory disease. In a previous report, we demonstrated the presence of immunoreactive cytoplasmic hypoxia inducible factor 1α (HIF1α), in both benign and malignant NE prostate cells. HIF1α and HIF1β are two subunits of HIF1, a transcription factor important for angiogenesis. The aim of this study was to elucidate whether the cytoplasmic stabilization of HIF1α in androgen independent NE differentiated prostate cancer is due to the presence of certain HIF1α isoforms.

Methods

We studied the HIF1α isoforms present in 8 cases of benign prostate hyperplasia (BPH) and 43 cases of prostate cancer with and without NE differentiation using RT-PCR, sequencing analysis, immunohistochemistry and in situ hybridization.

Results

We identified multiple isoforms in both benign and malignant prostate tissues. One of these isoforms, HIF1α1.2, which was previously reported to be testis specific, was found in 86% of NE-differentiated prostate tumors, 92% of HIF1α immunoreactive prostate tumors and 100% of cases of benign prostate hyperplasia. Immunohistochemistry and in situ hybridization results showed that this isoform corresponds to the cytoplasmic HIF1α present in androgen-independent NE cells of benign and malignant prostate tissue and co-localizes with immunoreactive cytoplasmic HIF1β.

Conclusion

Our results indicate that the cytoplasmic stabilization of HIF1α in NE-differentiated cells in benign and malignant prostate tissue is due to presence of an HIF1α isoform, HIF1α1.2. Co-localization of this isoform with HIF1β indicates that the HIF1α1.2 isoform might sequester HIF1β in the cytoplasm.